Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Aurinia Pharmaceuticals Inc
AUPH
Healthcare
Biotechnology
Aurinia Pharmaceuticals Inc. is a Canada-based fully integrated biopharmaceutical company. The Company is focused on delivering therapies to treat targeted patient populations with a high unmet medical need that are impacted by autoimmune, kidney and rare diseases. The Company has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis...
(LN) and continues to conduct pre-clinical, clinical, and regulatory activities to support the voclosporin development program. LUPKYNIS is a calcineurin inhibitor (CNI) immunosuppressant, that improves near and long-term outcomes in LN when used in combination with mycophenolate mofetil (MMF) and steroids. LUPKYNIS reduces cytokine activation and blocks interleukin IL-2 expression and T-cell mediated immune responses. Voclosporin, the active ingredient in LUPKYNIS, is made by a modification of a single amino acid of the cyclosporine molecule. Its product pipeline includes AUR200 and AUR300.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:AUPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(5881)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Mar 01, 2021 6:56am
Shorts Still a Factor
Although the value of short trades has been declining since the beginning of Feb, it still accounts for 28% of the total trades. Now that we're into March, new numbers should be coming out
...more
(53)
•••
ZoranSto
X
View Profile
View Bullboard History
Comment by
ZoranSto
on Feb 25, 2021 8:52am
RE:Nothing
Yes I think they are in good shape.....the share price just doesn't want to go up.....I thought we would have more interest.
Q Precious & Battery Metals to Drill Initial 1000 metres at La Corne and McKenzie East Gold Projects, Quebec
posted Apr 18, 2024 9:00am by
Q Precious & Battery Metals Corp
-
|
The Company is planning for an initial 1,000 metres of diamond drilling scheduled for mid- June 2024, with VMS targets on the La Corne South project at proposed depths ranging from 50 to 300 metres below surface as modelled by the EM survey and noted in historic drilling. TMC Geophysique completed deep-penetrating Pulse-EM -Time Domain Electromagnetic (TDEM) surveying on the claims that targeted ...read more
(392)
•••
jboom70
X
View Profile
View Bullboard History
Post by
jboom70
on Feb 25, 2021 8:47am
Nothing
wrong with those earnings,170% increase on sales same period last year. Anyone can see PT's are double current SP. Lets see if we can get a squeeze going, bears have been choking this to death.
(392)
•••
jboom70
X
View Profile
View Bullboard History
Post by
jboom70
on Feb 19, 2021 7:38am
Short positions
Link LOL If anyone was watching Zacks came out with a article a while ago and with a sell rating on this stock. Then they shorted it to drop the price. Then they accumulated and after put out
...more
(298)
•••
ddogold
X
View Profile
View Bullboard History
Comment by
ddogold
on Feb 16, 2021 9:40am
RE:More Upgrades
Took an partial position this morning .
(19)
•••
TrumpThis
X
View Profile
View Bullboard History
Post by
TrumpThis
on Feb 11, 2021 5:30pm
Robert Foster started the 1 in 100s chance!
Watch why Voclosporin should be propelling AUP to over $100! Very, very few biotech companies succeed in getting to market. Dr. Robert Foster incorporated Isotechnika Pharma in 1993, where he served
...more
(19)
•••
TrumpThis
X
View Profile
View Bullboard History
Post by
TrumpThis
on Feb 08, 2021 3:58pm
Reason for action & jump today?
Up 7% today on good volume. Can anyone expound on the reason? Was a total disappointment that the FDA approval didn't make a greater, lasting SP improvement. Also, anyone know why StockHouse
...more
(392)
•••
jboom70
X
View Profile
View Bullboard History
Comment by
jboom70
on Feb 02, 2021 6:08pm
RE:Insider
More buying from another insider.
(5881)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Feb 01, 2021 11:36am
Globe & Mail
Royal Bank of Canada is backing the country’s largest life sciences venture capital fund in two decades, making it one of the few Bay Street institutions to invest in the surging domestic sector
...more
(392)
•••
jboom70
X
View Profile
View Bullboard History
Post by
jboom70
on Feb 01, 2021 5:22am
Insider
Buy, 900 @ 16.14 Stephen Robertson
(5881)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Jan 29, 2021 11:36am
Streetwise Reports
Aurinia Pharma Shares Open at 52-Week High as FDA Approves Adult Lupus Nephritis Drug Source:
...more
(32)
•••
TimeScape
X
View Profile
View Bullboard History
Comment by
TimeScape
on Jan 26, 2021 3:13pm
RE:RBC
Thanks for posting the detailed analysis. Product sales estimates are roughly in line with what I was figuring. I said I thought it wouldn't be over $25 Cdn on Monday and it closed at
...more
(53)
•••
ZoranSto
X
View Profile
View Bullboard History
Comment by
ZoranSto
on Jan 26, 2021 2:03pm
RE:More Upgrades
With all the strong upgrades I am surprised yesterday's gains did not stick today. I am hoping this goes over $30 cnd over the next few months. GLTA
(5881)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Jan 26, 2021 7:48am
RBC
All figures are in US$ and their upside scenario target is also raised to US$38. GLTA January 26, 2021 Aurinia Pharmaceuticals Inc. First oral FDA-approved
...more
(5881)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Jan 26, 2021 7:31am
More Upgrades
Several more analysts on the Street raised their target prices for Aurinia Pharmaceuticals Inc. ( AUPH-Q +26.04%increase , AUP-T +26.71%increase ) in
...more
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Q Precious & Battery Metals Contracts First Class Drilling for Quebec Projects
Why the Tonopah Gold Project is One to Watch
Targeting Nevada and Ontario for the Critical Minerals Supply Chain
Asset Sale Allows Biotech Company to Refocus on the High Value Dermatological Market
Positive PEA for Uranium-Vanadium Deposit After-tax NPV 8%: $227.7 million with IRR: 38.9%
Fokus Mining Welcomes Luc Gervais To Its Board Of Directors